QuiAri Energy
Natural health product licensed in Canada
- Licence holder
- QuiAri, LLC
- NPN or DIN-HM
- 80110852
- Status
- Active licence
- Licence date
- 20 June 2021
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zingiber officinale Source : Rhizome | 8.3 mg | Not calculated |
| Calcium Source : Carbonate de calcium | 165 mg | 165,000 µg |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 1,200 mg Potency : 45 % Epigallocatechin 3-gallate | 150 mg | Not calculated |
| 1,3,7-triméthylxanthine Source : Caféine | 150 mg | Not calculated |
| Aristotelia chilensis Source : Fruit | 10 mg | Not calculated |
| Capsicum annuum Source : Fruit | 12.5 mg | Not calculated |
Non-medicinal ingredients
Triglycérides à chaîne moyenne, Dioxyde de silicium, Huile de tournesol, Dioxyde de titane, Croscarmellose de sodium, Poly(dextrose), Acide stéarique, Talc, Carmine, Cellulose microcristalline, Hypromellose, Son de riz, Laque d'aluminium bleu FD&C No 2
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of/Provides antioxidants. Helps (temporarily) to enhance (physical) energy. Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to reduce tiredness and fatigue. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Helps (temporarily) to support/promote mental sharpness/alertness. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80110852
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.